Kevin M Alexander

15PUBLICATIONS
80CO-AUTHORS
Disease surveillanceCardiology (incl. cardiovascular diseases)NanomedicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Condensed matter imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 23, 2026
Temporal Trends in Incidence and Prevalence of Transthyretin Amyloid Cardiomyopathy in the United States.

|Jun 09, 2026
Diagnostic Trends and Geographic Health Care Disparities Among Patients With Transthyretin Amyloid Cardiomyopathy.

|May 30, 2026
Association Between Predicting Risk of Cardiovascular Disease Events (PREVENT) Risk Scores and Subclinical Cardiovascular Disease: Insights From the Project Baseline Health Study.

|May 27, 2026
Contemporary Description of Clinical Characteristics and Outcomes in Patients with Hereditary ATTR Amyloidosis: Results from the Multicountry OverTTuRe Study.

|Feb 09, 2026
Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CM.

Nitasha Sarswat, Amrut V Ambardekar, Kevin M Alexander

|Nov 10, 2025
Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial.

Marianna Fontana, Pablo García-Pavía, Martha Grogan

Pageof 3

Frequent Collaborators

3 joint publications

Nitasha Sarswat

3 joint publications

Ahmad Masri

3 joint publications

Mathew S Maurer

2 joint publications

Marianna Fontana